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Abstract
Phenotypic variance heterogeneity across genotypes at a single nucleotide polymorphism
(SNP) may reflect underlying gene-environment (G×E) or gene-gene interactions. We
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Lipids Genetics Consortium (GLGC). Association
statistics from GIANT and GLGC are available here:
https://www.broadinstitute.org/collaboration/giant/
index.php/GIANT_consortium http://csg.sph.
umich.edu//abecasis/public/lipids2013/<http://csg.
sph.umich.edu/abecasis/public/lipids2013/>. Pv
values were calculated as explained in the
Methods. Pv values are made publicly available on
Dryad at doi:10.5061/dryad.q1m7t. Pi values are
modeled variance heterogeneity for blood lipids and BMI in up to 44,211 participants and
investigated relationships between variance effects (Pv), G×E interaction effects (with smok-
ing and physical activity), and marginal genetic effects (Pm). Correlations between Pv and
Pm were stronger for SNPs with established marginal effects (Spearman’s ρ = 0.401 for tri-
glycerides, and ρ = 0.236 for BMI) compared to all SNPs. When Pv and Pm were compared
for all pruned SNPs, only BMI was statistically significant (Spearman’s ρ = 0.010). Overall,
SNPs with established marginal effects were overrepresented in the nominally significant
part of the Pv distribution (Pbinomial <0.05). SNPs from the top 1% of the Pm distribution for
BMI had more significant Pv values (PMann–Whitney = 1.46×10−5), and the odds ratio of SNPs
with nominally significant (<0.05) Pm and Pv was 1.33 (95% CI: 1.12, 1.57) for BMI. More-
over, BMI SNPs with nominally significant G×E interaction P-values (Pint<0.05) were
enriched with nominally significant Pv values (Pbinomial = 8.63×10−9 and 8.52×10−7 for SNP ×
smoking and SNP × physical activity, respectively). We conclude that some loci with strong
marginal effects may be good candidates for G×E, and variance-based prioritization can be
used to identify them.
Author summary
Most contemporary studies of gene-environment interactions focus on gene variants that
are known to bear strong and reliable associations with the traits of interest. The strategy
is intuitive because it helps limit the number of tests performed by focusing on a relatively
small number of gene variants. However, this approach is predicated on an implicit
assumption that these loci are strong candidates for interactions owing to their established
relationships with the index traits. The counter-argument is that, because these loci have
highly consistent signals within and between populations that vary by environmental
characteristics, the probability that these variants interact with other factors is low. The
current analysis tests whether variants with strong marginal effects signals (i.e., those pri-
oritized through conventional genome-wide association analyses) are strong or weak can-
didates for gene-environment interactions. Here we describe analyses focused on lipids
and BMI that test this hypothesis by comparing marginal effect signals with variance effect
signals and those derived from explicit genome-wide, gene-environment interaction anal-
yses. We conclude that for BMI, there are features of the top-ranking marginal effect loci
that render them stronger candidates for interactions than is true of variants with weaker
marginal effects signals. These findings are likely to help optimize the efficiency of future
gene-environment interaction analyses by providing evidence-based rankings for strong
candidate loci.
Introduction
Gene-environment (G×E) interactions may contribute to complex diseases, but their detection
has proven challenging; hence, a variety of approaches have been developed to enhance power.
Most G×E analyses focus on loci that are strong biological candidates [1] or those with highly
significant marginal effects [2]. The latter approach is attractive because these loci are available
in many large cohorts, and can be conveniently followed-up with interaction analyses if envi-
ronmental data are accessible. Moreover, selecting SNPs with strong and reproducible
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marginal effect signals is a pragmatic data-reduction step that may improve power [3],
although this approach risks omitting other promising candidates [4].
In a linear regression setting, the presence of interaction effects drives phenotypic variance
heterogeneity by genotype [3,5]. Exploiting variance heterogeneity as a signature of interac-
tions is appealing because, unlike standard approaches for assessing G×E interactions, no
explicit information about environmental exposures is needed [6] and multiple exposures can
be simultaneously considered.
Here we explored whether loci identified in large-scale genome-wide association studies
(GWAS) of blood lipids and body mass index (BMI) are strong candidates for G×E interac-
tions by comparing genome-wide variance heterogeneity P-value distributions generated
using Levene’s test against P-value distributions for marginal effects and explicit G×E interac-
tion effects (for smoking and physical activity).
Results
We assessed between-genotype variance heterogeneity for up to 1,927,671 directly genotyped
or imputed SNPs (HapMap II CEU reference panel [7]) that passed quality control (QC).
Meta-analyses of Levene’s test summary statistics [8] were performed for BMI (n44,211 par-
ticipants), and blood concentrations of high-density lipoprotein cholesterol (HDL-C)
(n34,315), low-density lipoprotein cholesterol (LDL-C) (n34,180), total cholesterol (TC)
(n34,318) and triglycerides (TG) (n34,110). We then obtained marginal effects results for
the same index traits and SNPs from publicly available GWAS summary data from the GIANT
(Genetic Investigation of ANthropometric Traits) Consortium [9] and GLGC (Global Lipids
Genetics Consortium) [10,11].
We compared the genome-wide marginal effects with between-genotype variance heteroge-
neity results for each of the five cardiometabolic traits by calculating the association between
marginal effects (Pm) and variance heterogeneity (Pv) P-values using the rank-based Spearman
correlation (ρ). This was done using a set of 42,710 pruned SNPs produced using the--indep-
pairwise command in PLINK (see Materials and Methods) to account for linkage disequilib-
rium (LD) among variants.
As shown in Table 1 (see also Fig 1A and S1 Table), the Spearman’s ρ for the association
between Pm and Pv for all pruned SNPs was of very small magnitude and only statistically sig-
nificant for BMI. The exclusion of SNPs based on progressively more conservative Pm thresh-
olds (Pm<0.05; Pm<10−4; previously established loci with Pm<5×10−8 in external datasets),
saw corresponding improvements in the magnitude of these correlations, which were statisti-
cally significant for all traits except TC when focusing on previously established loci. The BMI
correlation at the Pm<0.05 threshold, as well as the test of equality with ρ for all SNPs, was sta-
tistically significant, suggesting concordance between marginal and variance signals at a nomi-
nal level of significance. The odds ratio (OR) for a SNP to have both Pm<0.05 and Pv<0.05 as
compared to Pv0.05 was 1.33 (95% CI: 1.12, 1.57) for BMI while the 95% CIs of ORs for
other traits included 1. On the other hand, the P-value for a non-zero ρ for TG was statistically
significant when focusing on the established loci and at Pm<10−4, suggesting concordance
between marginal and variance signals at more conservative Pm thresholds.
We further compared Pm with interaction P-values from exposure-specific (smoking and
physical activity) genome-wide interaction tests for BMI (Pint); this was only done for BMI
owing to the requirement for an adequately powered external dataset (such a dataset was
accessible through the GIANT consortium) (Table 2). Marginal effects GWAS were performed
by strata of smokers vs. non-smokers and physically active vs. inactive participants (n =
210,316 European-ancestry adults [12]) respectively, and a heterogeneity test [12] was used to
Characterization of BMI and lipid loci as candidates for G×E interactions
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generate exposure specific Pint distributions. Spearman ρ for the pruned set of SNPs in the
SNP × physical activity and the SNP × smoking analyses were low and not statistically
Fig 1. A. Percentile-scaled ranks of GWAS-derived SNPs for lipid traits on the genome-wide
distribution of P-values from Levene’s meta-analysis. For each lipid trait (HDL-C, LDL-C, TG and TC
on the vertical axis) we ranked Pv from Levene’s test for all SNPs from lowest to highest so that the lowest Pv
for a given trait was assigned a rank equal to 1. We scaled ranks into percentiles such that the lowest Pv
corresponded to the 100th percentile. We then plotted percentile-scaled ranks of GWAS-derived loci (black
sticks on the blue axis) on the distribution of percentile-scaled ranks of genome-wide Pv (blue axis) for each
trait and marked in red loci with Pv<0.05. Loci names are presented above the axis for Pv distribution of a
given trait and are positioned in the same order as percentile-scaled ranks of GWAS-derived loci, but are
equally spaced to facilitate cross-trait comparison (loci names with Levene’s test Pv<0.05 are highlighted in
red). To the left of each axis we present counts of GWAS-derived loci with Pv<0.05 and total number of
GWAS-derived loci in the analysis separated by a dash, as well as the P-value for the binomial test (Pbinomial).
B. Percentile-scaled ranks of GWAS-derived SNPs for BMI on the genome-wide distribution of P-
values obtained from Levene’s test (Pv) and between-strata difference test P-values (Pint) from the
‘SNP × Physical Activity’ and ‘SNP × Smoking’ interaction tests for BMI. For each analysis, we ranked P-
values for all SNPs from lowest to highest so that the lowest P-value for a given trait was assigned a rank
equal to 1. We scaled ranks into percentiles such that the lowest P-value corresponded to the 100th percentile.
We then plotted percentile-scaled ranks of GWAS-derived loci (black sticks on the blue axis) on the
distribution of percentile-scaled ranks of genome-wide P-values (blue axis) from all four approaches and
marked in red loci with Pv<0.05 or Pint<0.05 (or 95th percentile for average rank between SNP × PA and SNP
× Smoking). Loci names are presented above the axis for the P-value distribution of a given trait and are
positioned in the same order as the percentile-scaled ranks of GWAS-derived loci, but are equally spaced to
facilitate cross-trait comparisons (loci names with Pv<0.05 or Pint<0.05 are highlighted in red). To the left of
each axis conveying each respective P-value distribution, we present counts of GWAS-derived BMI loci with
Pv<0.05 or Pint<0.05 (or 95th percentile for the average rank of the SNP × PA and SNP × Smoking interaction
tests) and the total number of GWAS-derived loci in the analysis separated by a dash, as well as the P-value
for the binomial test (Pbinomial).
https://doi.org/10.1371/journal.pgen.1006812.g001
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significant (Table 2). We also compared Pint values and Pv values for BMI. Spearman’s ρ for the
pruned set of SNPs were low and not statistically significant.
We next tested if the number of previously established marginal effect SNPs (Pm<5×10−8)
that were also nominally significant (Pv<0.05) for variance heterogeneity was greater than
expected by chance (Tables 3 and 4, Fig 1). For 4 out of the 5 index traits, we observed enrich-
ment at the lower end of the Pv distribution (Pv<0.05) for the established GWAS-derived lead
SNPs. Thus, the nominally significant regions of the Pv distributions were generally enriched
for GWAS-derived loci.
We also performed enrichment analyses to test if previously established marginal effects
SNPs (Pm<5×10−8) are enriched for nominally significant (Pint<0.05) interactions in the SNP
× physical activity or SNP × Smoking analyses, but no enrichment was observed (Table 3; Fig
1B). By contrast, for the physical activity and smoking interaction tests (using all pruned
SNPs), the lower end of the Pint distribution (Pint<0.05) was enriched with SNPs that were
nominally significant in the Levene’s test analysis (Pv<0.05) (Table 4). This enrichment trans-
lated into an OR of 1.08 (95% CI: 1.01, 1.14) for a SNP to have Pint<0.05 given Pv<0.05 vs.
Table 2. Spearman correlations between Pint in SNP × Physical Activity and SNP × Smoking on BMI analyses and marginal effects Pm or heteroge-
neity of variance from Levene’s test Pv.
Characteristic Max Sample
Size
Max Sample Size PA/
Smoking
All SNPs SNPs with Pm<0.05 Known SNPs
# SNPs Spearman
ρ
P-
value
# SNPs Spearman
ρ
P-
value
# SNPs Spearman
ρ
P-value
Marginal effects Pm
PA × SNP 322,144 180,271 41838 0.001 0.761 2142 0.029 0.176 71 -0.003 0.978
Smoking ×
SNP
322,144 210,306 41371 -0.004 0.429 2351 0.010 0.619 71 0.205 0.0863
Levene’s test for homogeneity of variance Pv
PA × SNP 44,211 180,271 41838 0.005 0.35 2142 -0.003 0.884 71 0.052 0.669
Smoking ×
SNP
44,211 210,306 41371 0.004 0.401 2351 -0.023 0.265 71 0.110 0.360
PA: physical activity; BMI: body mass index; SNP: single nucleotide polymorphism; Pv: Variance (Levene’s) test P-value; Pm: Marginal (linear regression)
test P-value
https://doi.org/10.1371/journal.pgen.1006812.t002
Table 3. Enrichment of variance and gene × environment interaction nominally significant results
with GWAS-derived loci.
Trait Analysis Total SNPs/
Observed SNPs with P<0.05 (Expected)
Pbinomial
BMI Levene’s 71/10 (3.6) 3×10−3
SNP × PA 71/4 (3.6) 0.48
SNP × Smoking 71/5 (3.6) 0.28
Average for SNP × PA & SNP × Smoking 71/2 (3.6) 0.88
TG Levene’s 40/9 (2) 1×10−4
LDL-C Levene’s 53/8 (2.7) 5×10−3
HDL-C Levene’s 68/6 (3.4) 0.12
TC Levene’s 69/9 (3.5) 7×10−3
PA: physical activity; BMI: body mass index; GWAS: genome-wide association study; HDL-C: low-density
lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; SNP: single nucleotide polymorphism;
TC: total cholesterol; TG: triglycerides
https://doi.org/10.1371/journal.pgen.1006812.t003
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Pv0.05 for SNP × physical activity interaction. The corresponding OR for the SNP × smoking
interaction test was not significant (OR = 1.02; 95% CI: 0.96, 1.08).
Finally, in the pruned SNP-set we used the Mann–Whitney U test to probe for systematic
differences in Pv and Pm ranks. P-values were ordered from least significant to most significant,
and the lowest 100th centile (i.e. the most significantly associated SNPs) was compared to the
remaining 99th percentile for each of the five traits. For BMI, SNPs in the lowest 100th centile
of the Pm distribution had markedly higher Pv ranks (i.e. more significant Pv) than the remain-
ing SNPs (PMann–Whitney = 1.46×10−5; Table 5). Even when excluding previously established
lead SNPs (Pm<5×10−8) for BMI (or SNPs +/-500kb proximal), SNPs from the lowest 100th
centile of the Pm rank-ordered distribution had higher Pv ranks than the remaining SNPs
(PMann–Whitney = 4.30×10−4; Table 5). Conversely, no difference in Pv ranks was observed for
SNPs from the lowest 100th centile of the Pm rank-ordered distribution for the four blood
lipid traits; this may reflect trait-specific G×E effects or differences in statistical power by trait.
No differences in Pv ranks between SNPs from the lowest 99th centile of the Pm rank-ordered
distribution compared to SNPs from the 98th to 1st centiles of the distribution were observed
for any trait (PMann–Whitney>0.05; Table 5). Similarly, no difference in Pm ranks was observed
for SNPs from the lowest 100th centile of the Pv rank-ordered distribution for any traits
(PMann–Whitney>0.05; Table 6).
Table 4. Enrichment of SNPs with nominally significant Pint for test of SNP × Smoking and
SNP × Physical Activity interaction for BMI (Pint<0.05) by SNPs with nominally significant Levene’s
test (Pv<0.05).
Analysis Total SNPs with Pint<0.05/ Observed SNPs with Pint<0.05 & Pv<0.05
(Expected)
Pbinomial
SNP × PA 2142/159 (107.1) 8.52×10−7
SNP ×
Smoking
2351/182 (117.6) 8.63×10−9
BMI: body mass index; PA: physical activity; SNP: single nucleotide polymorphism; Pv = Variance
(Levene’s) test P-value; Pint = G×E interaction (heterogeneity) test P-value; Pbinomial = significance of
observing Pv<0.05 more than expected by chance
https://doi.org/10.1371/journal.pgen.1006812.t004
Table 5. Comparison of Levene’s test Pv ranks from different centiles of the Pm rank-ordered distribution for the index traits.
Trait Known
SNPs
Min Pm from
100th centile
Max Pm
from 100th
centile
Median Pv
rank for
100th
centile
Median Pv
rank for
99th-1st
centiles
Mann-
Whitney P-
value
Min Pm
from 99th
centile
Max Pm
from 99th
centile
Median Pv
rank for
99th
centile
Median Pv
rank for
98th-1st
centiles
Mann-
Whitney
P-value
BMI Included 4.78×10−91 5.82×10−3 58.82 49.93 1.46×10−5 5.86×10−3 1.85×10−2 52.79 49.91 0.42
BMI Excluded 3.59×10−6 8.56×10−3 55.78 49.95 4.30×10−4 8.73×10−3 2.18×10−2 52.60 49.93 0.36
HDL-C Included 3.56×10−573 6.48×10−3 51.49 49.99 0.47 6.48×10−3 1.67×10−2 50.49 49.98 0.92
HDL-C Excluded 6.68×10−11 9.94×10−3 51.45 49.99 0.77 9.95×10−3 2.09×10−2 51.06 49.98 0.47
LDL-C Included 3.80×10−143 7.14×10−3 53.11 49.98 0.52 7.18×10−3 1.75×10−2 48.44 49.99 0.85
LDL-C Excluded 2.03×10−11 9.88×10−3 53.42 49.97 0.38 9.90×10−3 2.09×10−2 48.37 49.99 1.00
TG Included 2.23×10−113 8.18×10−3 53.73 49.98 0.32 8.19×10−3 1.92×10−2 52.42 49.95 0.63
TG Excluded 1.00×10−10 1.06×10−2 51.27 49.99 0.64 1.06×10−2 2.21×10−2 53.23 49.95 0.41
TC Included 1.41×10−107 5.85×10−3 52.03 49.98 0.32 5.87×10−3 1.49×10−2 51.21 49.97 0.62
TC Excluded 3.11×10−11 9.14×10−3 49.43 50.01 0.66 9.15×10−3 1.91×10−2 50.12 50.01 0.93
BMI: body mass index; HDL-C: low-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; SNP: single nucleotide polymorphism; TC:
total cholesterol; TG: triglycerides; Pv: Variance (Levene’s) test P-value; Pm: marginal (linear regression) test P-value
https://doi.org/10.1371/journal.pgen.1006812.t005
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To assess whether a trait with a non-normal distribution (e.g. BMI) or strong marginal
associations could cause spurious association between the marginal and variance signals, we
recapitulated the analysis pipeline (correlation analysis, enrichment analysis, comparisons of
rank Pm and Pv values) in simulations described in the Materials and Methods. Careful assess-
ment of results emanating from these simulations did not reveal evidence of type I error infla-
tion caused by the non-normal distribution of an outcome trait nor strong marginal effects.
For instance, we extracted correlation P-values of Pm, Pv and Pint generated from 5,000 simula-
tions. QQ-plots of the 5,000 correlation P-values, 2,500 binomial P-values, and 2,500 Mann-
Whitney U test P-values revealed no inflation (S1A–S1C Fig, S2A and S2B Fig and S3A and
S3B Fig, respectively). Repeating these analyses on subsets of SNPs with low Pm values did not
materially change the results.
Discussion
Collectively, our analyses highlight a few variants with genome-wide significant marginal
effects that may be strong candidates for G×E interactions owing to their strong concurrent
variance heterogeneity P-values. For BMI, such SNPs are also overrepresented in the nomi-
nally significant part of the Pv distribution. FTO is an excellent example, as it conveys strong
marginal effects [13], exhibits high between-genotype heterogeneity here (Tables 2 and 3 and
Fig 1B) and elsewhere [5], and reportedly interacts with physical activity, diet and other life-
style exposures [2,14,15] and is associated with macronutrient intake [16,17].
Although variance heterogeneity tests are potentially powerful screening tools for G×E
interactions, like most interaction tests, they may be bias prone. For example, apparent differ-
ences in phenotypic variances across genotypes may be caused by scaling, particularly when
the phenotypic means also differ substantially [18], such that the per-genotype means and vari-
ances for index traits are correlated. However, where necessary we transformed variables, and
the correlations between Pm and Pv were generally weak, excluding this as a likely source of
bias. Using simulated data, we investigated whether the non-normal distribution of a trait can
cause a spurious association between marginal and variance signals, which we show is highly
improbable. Through further simulations, we assessed whether SNPs with large marginal
effects inflate Pv, but observed no inflation, indicating that large genetic marginal effects do
Table 6. Comparison of marginal effects Pm ranks from different centiles of the Levene’s test Pv rank-ordered distribution for the index traits.
Trait Known
SNPs
Min Pv from
100th
centile
Max Pv
from 100th
centile
Median Pm
rank for
100th
centile
Median Pm
rank for
99th-1st
centiles
Mann-
Whitney
P-value
Min Pv
from 99th
centile
Max Pv
from 99th
centile
Median Pm
rank for
99th
centile
Median Pm
rank for
98th-1st
centiles
Mann-
Whitney
P-value
BMI Included 2.95×10−7 6.31×10−3 51.28 49.53 0.51 6.33×10−3 1.30×10−2 53.57 49.53 0.13
BMI Excluded 2.95×10−7 6.38×10−3 51.40 49.48 0.42 6.38×10−3 1.30×10−2 53.50 49.44 0.17
HDL-C Included 2.04×10−5 9.44×10−3 46.28 50.04 0.52 9.45×10−3 1.90×10−2 53.06 50.01 0.44
HDL-C Excluded 2.04×10−5 9.45×10−3 46.42 50.05 0.37 9.47×10−3 1.89×10−2 53.37 50.01 0.31
LDL-C Included 1.06×10−8 9.12×10−3 52.96 49.98 0.19 9.15×10−3 1.88×10−2 50.78 49.96 0.99
LDL-C Excluded 1.44×10−5 9.37×10−3 50.39 49.99 0.64 9.37×10−3 1.92×10−2 51.85 49.97 0.68
TG Included 2.45×10−6 8.39×10−3 48.93 50.01 0.60 8.39×10−3 1.78×10−2 51.75 50.01 0.53
TG Excluded 2.45×10−6 8.37×10−3 49.23 50.01 0.66 8.39×10−3 1.78×10−2 51.92 50.00 0.51
TC Included 3.28×10−5 1.08×10−2 51.61 49.98 0.16 1.08×10−2 2.09×10−2 50.29 49.98 0.92
TC Excluded 3.28×10−5 1.10×10−2 51.23 50.00 0.33 1.10×10−2 2.10×10−2 49.92 50.00 0.93
BMI: body mass index; HDL-C: low-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; SNP: single nucleotide polymorphism; TC:
total cholesterol; TG: triglycerides; Pv: Variance (Levene’s) test P-value; Pm: marginal (linear regression) test P-value
https://doi.org/10.1371/journal.pgen.1006812.t006
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not artificially inflate variance heterogeneity to a meaningful extent, and SNPs with low Pm
and low Pv-values are thus likely to be strong candidates for G×E interactions, at least in the
case of BMI. It might also be that combining populations from ancestral (e.g., hunter-gather-
ers) and contemporary environments increases variance heterogeneity owing to diversity in
population substructure rather than G×E interactions per se [19]. However, this seems unlikely
here, as the cohorts examined are from Westernized European-ancestry populations.
There are several additional explanations for between-genotype variance heterogeneity,
such as variance misclassification that can occur when the index variant is located within a
haplotype containing rare functional variants that convey strong marginal effects [5]. Hence,
although variance heterogeneity tests represent a useful data-reduction step, before conclu-
sions are drawn about the presence or absence of G×E interactions, index variants should be
validated by testing their interactions with explicit environmental exposures, as we did here
with smoking and physical activity. However, genome-wide G×E interactions datasets are not
comprised of functionally validated G×E interactions, as no such resource is currently avail-
able for human complex traits. This limitation inhibits the extent to which causal effects can be
attributed to the top-ranking loci and their interactions with smoking or physical activity.
We conclude that the common approach of prioritizing loci with established genome-wide
significant association signals without further discrimination for G×E interaction analyses
might be useful, but the efficiency of such analyses could be substantially improved by focusing
on variants with low P-values for both variance heterogeneity and marginal effects. We provide
these rankings here to facilitate this approach.
Materials and methods
A detailed project flow-chart is shown in Fig 2.
Study sample
We performed a genome-wide search for SNPs whose associations with the following traits are
characterized by high between-genotype variance heterogeneity: BMI, TC, TG, HDL-C and
LDL-C. The variance heterogeneity analyses were performed using Levene’s test [20] in up to
Fig 2. Data flow-chart. Three sources of genome-wide results were used: i) meta-analysis of Levene’s test
results for between-genotype heterogeneity of phenotypic variances; ii) published results for marginal effects
genome-wide association studies undertaken by the GIANT and GLGC consortia; iii) published results for
SNP × physical activity and SNP × smoking in BMI (from the GIANT consortium).
https://doi.org/10.1371/journal.pgen.1006812.g002
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44,211 participants of European descent from seven population-based cohorts. Descriptions of
these cohorts are presented in S2 Table. To minimize bias that might result from unequal sam-
ple sizes between SNPs when calculating the correlations between the P-values from the mar-
ginal (Pm) and variance heterogeneity (Pv) meta-analyses, we restricted the sample size for
analyses to 26,000 participants for BMI and to 24,000 participants for lipid traits (S4 Fig).
Genotyping and imputation
A detailed summary of sample sizes, genotyping platforms, genotype calling algorithms, sam-
ple and SNP quality control filters, and analysis software for all participating cohorts are pro-
vided in S2 and S3 Tables. For each individual, SNPs were imputed using the CEU reference
panel of HapMap II [7] (S2 Table). We excluded SNPs with low imputation quality (below 0.3
for MACH, 0.4 for IMPUTE, and 0.8 for PLINK imputed data), Hardy-Weinberg equilibrium
P<10−6, directly genotyped SNP call rate< 95%, and minor allele frequency (MAF) < 1%.
Selection of SNPs identified through GWAS
We identified SNPs that have been robustly associated (P<5x10-8) with the five cardiometa-
bolic traits in European ancestry populations: 77 SNPs associated with BMI discovered by
GIANT [9]; and 58 SNPs associated with LDL-C, 71 SNPs associated with HDL-C, 74 SNPs
associated with TC, and 40 SNPs associated with TG [10,11] discovered by GLGC.
Variance heterogeneity analyses
We used Levene’s test [20] to identify SNPs that show heterogeneity of phenotypic variances
(σi2) across the three genotype groups at each SNP locus (i = 0, 1, or 2). We first log10 trans-
formed all five traits followed by a z-score transformation by subtracting the sample mean and
dividing by the sample standard deviation (SD), and further Winsorized the z-score values at 4
SD. The transformed phenotype Y was then used to calculate Z, defined by the absolute devia-
tion of each participant’s phenotype from the sample mean of his or her respective genotype
group at a given SNP locus. For each trait, participating cohorts provided the necessary sum-
mary statistics for each genotype at each marker [8]. Specifically, the per genotype group
counts (n0s, n1s, n2s), per genotype means (Z0s; Z1s; Z2s), and per genotype group variances of Z
(σ0s2,σ1s2,σ2s2) were centrally collected and meta-analyzed. The minimum number of observa-
tions per genotype group required is 30 participants per cohort.
Meta-analyses were performed using the following formula, derived previously [8]:
L ¼
ðN   3Þ
ð3   1Þ

ð
X2
i¼0
gi  ð
X
s
Zis  oisÞ
2
  ð
X2
i¼0
X
s
Zis  ois  giÞ
2
Þ
X2
i¼0
ð
X
s
ðsZis
2  ois  
sZis
2
N  gi
þ Zis
2  oisÞ  gi   ðð
X
s
Zis  oisÞ
2
 giÞÞ
Where N is the combined sample size, Zis and sZis
2 are the sample mean and variance of
Z in the ith genotype group of the sth study, respectively. When combining summary-level data
to calculate the Levene’s test statistics L, the following natural weights ωis and γi were calcu-
lated: ois ¼
nisX
s
nis
and gi ¼
ni
N, where ni the sum of genotype counts in the i
th genotype group
across all participating cohorts. These weights are determined by the frequency of the marker
amongst the cohorts, such that the sum of both weights is equal to 1, i.e.
X
s
ois ¼ 1 and
X
i
gi ¼ 1. The meta-analysis Levene’s test P-value is obtained by comparing L to an F-distri-
bution with df1 = 2 and df2 = N-3.
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Comparison between marginal effects and variance heterogeneity P-
values
Marginal effects P-values for BMI and the relevant lipid traits were obtained from publically
available GWAS summary data from the GIANT [9] and GLGC [10,11] consortia, respectively
(all cohorts included here in the Levene’s meta-analysis were also included in the GIANT and
GLGC datasets).
To illustrate our findings, we rank-ordered the P-values (from lowest to highest) from both
marginal effects and variance effects analyses for all 1,927,671 SNPs so that the lowest P-value
for a given trait was assigned a rank equal to the lowest 100th centile. These rank-scaled distri-
butions for Pm for all five traits are presented in Fig 1.
We calculated Spearman’s correlations for each of the five cardiometabolic traits between
Pm and Pv. This was done using a pruned set of SNPs. Pruning was performed in the Twin-
Gene cohort using the--indep-pairwise 50 5 0.1 command in PLINK [21] by calculating LD (r2)
for each pair of SNPs within a window of 50 SNPs, removing one of a pair of SNPs if r2>0.1;
we proceeded by shifting the window 5 SNPs forwards and repeating the procedure. Spear-
man’s correlations were computed for categories of SNPs: i) all pruned SNPs, ii) the subset of
SNPs that was nominally significant (Pm<0.05) in the marginal effects analysis, iii) the subset
of SNPs with Pm<10−4 in the marginal effects analysis, and iv) SNPs that were previously
established in conventional marginal effects GWAS meta-analyses (Pm<5×10−8). We also
compared Spearman’s correlations between these categories of SNPs using the test for equality
of two correlations [22].
Next, we performed enrichment analyses to test if there was a higher number of established
SNPs in the nominally significant variance P-value (Pv<0.05) distribution than expected by
chance under the binominal distribution.
We also tested if there is a difference in Pv ranks for SNPs from the lowest 100th centile of
the Pm rank-ordered distribution for all five traits and the rest of SNPs in the pruned set of
SNPs using the Mann–Whitney U test, including and excluding established SNPs (or SNPs
that were +/-500kb from the reported lead SNP). This analysis was repeated for SNPs from the
99th centile vs SNPs from 1st to 98th centiles of the Pm rank-ordered distribution. The same
Mann–Whitney U tests were used to study differences in Pm ranks for SNPs from the lowest
100th and 99th centiles of the Pv rank-ordered distribution and the rest of SNPs in the pruned
set of SNPs.
All analyses were performed using Stata 12 (StataCorp LP, TX, USA), unless specified
otherwise.
SNP × Physical activity and SNP × Smoking interaction analyses for the
outcome of BMI
We used now published data from 210,316 European-ancestry adults (from the GIANT con-
sortium) pertaining to marginal effects meta-analyses for BMI that had been performed sepa-
rately by strata of smoking (45,968 smokers vs. 164,355 non-smokers) [23]. The genetic
marginal effect estimates, calculated separately within each of the two strata, were compared
using a heterogeneity test [12] to infer the presence or absence of SNP × smoking interaction
effects. The same analyses were performed using physical activity as a binary stratifying vari-
able in up to 180,287 European-ancestry adults (42,065 physically active vs. 138,222 physically
inactive) [24]. We calculated Spearman correlations between the P-values derived from the
marginal effects meta-analysis and the Pint from the interaction effects meta-analysis (i.e., the
between-strata heterogeneity test for SNP × smoking and SNP × physical activity interactions
from the GIANT consortium); these tests were undertaken for all SNPs and those SNPs that
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were nominally significant (Pm<0.05) in the marginal effects analysis. We then performed
enrichment analyses to test if the numbers of nominally significant (Pint<0.05) GWAS-derived
SNPs from both SNP × physical activity and SNP × smoking analyses were greater than
expected by chance under the binomial distribution. We further calculated the OR of having
Pint<0.05 given Pv<0.05 versus Pv0.05 both SNP × physical activity and SNP × smoking inter-
action analyses in a pruned set of TwinGene SNPs produced using the—indep-pairwise 50 5
0.8 command in PLINK [21].
Thereafter, we calculated the average rank for each SNP’s ranking on the Pint rank-ordered
distributions from the SNP × smoking and SNP × physical activity interaction analyses and per-
formed enrichment analysis using these average ranks with>95th centile instead of Pint<0.05
as the cut-off.
Simulations
We simulated genetic data for 44,000 individuals from a pruned set of 50,335 SNPs with allele
frequencies, effect estimates and Pm values drawn from the GIANT consortium. We generated
an outcome trait by summing the products of the simulated allele counts and effect estimates
over all SNPs for each individual, and subsequently added a randomly generated non-normal
error term such that the trait resembles the observed distribution of the transformed BMI trait
used in the main (real data) analyses. We also simulated a fixed binary interacting factor with
30% prevalence. Using this simulated dataset, we calculated Pm, Pv and Pint values for each
SNP and undertook i) pairwise Spearman correlation analyses between Pm, Pv and Pint values
(5,000 simulations), ii) enrichment analysis using binomial tests (2,500 simulations) and iii)
Mann-Whitney U tests to determine systematic differences in Pv and Pm ranks (2,500 simula-
tions). Following the same pipeline, we created additional simulated datasets narrowing down
SNPs to i) those with Pm values from the lowest percentile (n = 504; highest Pm = 5×10−3) and
to ii) genome-wide significant SNPs (n = 71; Pm<5×10−8), and tested the pairwise Spearman
correlation for Pm, Pv and Pint values (1,000 simulations for both sets). Simulations were run
using the statistical software R (v. 3.3.2).[25]
Supporting information
S1 Fig. A: Quantile-quantile plot of Spearman correlation test P-values for ranks of Pm
and Pv. Quantile-quantile plot of Spearman correlation test P-values for ranks of Pm and Pv.
The figure illustrates 5,000 Spearman correlation P values testing for correlation between Pm
and and Pv values drawn from a simulated dataset of 44,000 individuals and 50,335 SNPs. In
the figure, distribution under the null hypothesis is represented as a black line while its 95%
confidence interval is represented as dashed gray lines. The dashed red line represents the cor-
relation P value obtained from the “real data” analysis presented in the main text. B. Quantile-
quantile plot of Spearman correlation test P-values for ranks of Pm and Pint. Quantile-quan-
tile plot of Spearman correlation test P-values for ranks of Pm and Pint. The figure illustrates
5,000 Spearman correlation P values testing for correlation between Pm and and Pint values
drawn from a simulated dataset of 44,000 individuals and 50,335 SNPs. In the figure, distribu-
tion under the null hypothesis is represented as a black line while its 95% confidence interval is
represented as dashed gray lines. C. Quantile-quantile plot of Spearman correlation test P-
values for ranks of Pint and Pv. Quantile-quantile plot of Spearman correlation test P-values
for ranks of Pint and Pv. The figure illustrates 5,000 Spearman correlation P values testing for
correlation between Pint and and Pv values drawn from a simulated dataset of 44,000 individu-
als and 50,335 SNPs. In the figure, distribution under the null hypothesis is represented as a
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black line while its 95% confidence interval is represented as dashed gray lines.
(TIF)
S2 Fig. A. Quantile-quantile plot of binomial test P-values for enrichment of variants with
Pv<0.05 among variants with Pm<0.05. Quantile-quantile plot of binomial test P-values for
enrichment of variants with Pv<0.05 among variants with Pm<0.05. The figure illustrates
2,500 binomial P values testing for enrichment of variants with Pv<0.05 among all variants
with Pm<0.05. Pv and and Pm values drawn from a simulated dataset of 44,000 individuals and
50,335 SNPs. In the figure, distribution under the null hypothesis is represented as a black line
while its 95% confidence interval is represented as dashed gray lines. B. Quantile-quantile
plot of binomial test P-values for enrichment of variants with Pv<0.05 among variants
with Pint<0.05. Quantile-quantile plot of binomial test P-values for enrichment of variants
with Pv<0.05 among variants with Pint<0.05. The figure illustrates 2,500 binomial P values
testing for enrichment of variants with Pv<0.05 among all variants with Pint<0.05. Pv and and
Pint values drawn from a simulated dataset of 44,000 individuals and 50,335 SNPs. In the fig-
ure, the distribution under the null hypothesis is represented as a black line while its 95% con-
fidence interval is represented as dashed gray lines. The dashed red line represents the
correlation P value obtained from the “real data” analysis presented in the main text.
(TIF)
S3 Fig. A. Quantile-quantile plot of Mann-Whitney U test P-values for systematic differ-
ences in Pv ranks among variants with top ranking and lower ranking Pm values. Quantile-
quantile plot of Mann-Whitney U test P-values for systematic differences in Pv ranks among
variants with top ranking and lower ranking Pm values. The figure illustrates 2,500 Mann-
Whitney U P values testing for systematic differences in Pv ranks among those variants with
the most significant Pm values (100th percentile of Pm distribution) and the remaining variants
(1–99 percentile of Pm distribution). Pv and and Pm values drawn from a simulated dataset of
44,000 individuals and 50,335 SNPs. In the figure, distribution under the null hypothesis is
represented as a black line while its 95% confidence interval is represented as dashed gray
lines. The dashed red line represents the correlation P value obtained from the “real data” anal-
ysis presented in the main text. B. Quantile-quantile plot of Mann-Whitney U test P-values
for systematic differences in Pm ranks among variants with top ranking and lower ranking
Pv values. Quantile-quantile plot of Mann-Whitney U test P-values for systematic differences
in Pm ranks among variants with top ranking and lower ranking Pv values. The figure illus-
trates 2,500 Mann-Whitney U P values testing for systematic differences in Pm ranks among
those variants with the most significant Pv values (100th percentile of Pv distribution) and the
remaining variants (1–99 percentile of Pv distribution). Pv and and Pm values drawn from a
simulated dataset of 44,000 individuals and 50,335 SNPs. In the figure, distribution under the
null hypothesis is represented as a black line while its 95% confidence interval is represented as
dashed gray lines. The dashed red line represents the correlation P value obtained from the
“real data” analysis presented in the main text.
(TIF)
S4 Fig. Quantile-quantile plots of Levene’s test P-values for SNP associations with lipid
traits and BMI. Associations between SNPs and BMI (A), LDL (B), HDL (C), TG (D), TC (E)
are presented. Only SNPs with N 26,000 samples for BMI and N 24,000 for lipid traits are
shown. In each sub-figure, distribution under the null hypothesis is represented as a black line
while its 95% confidence interval is represented as dashed gray lines.
(TIF)
Characterization of BMI and lipid loci as candidates for G×E interactions
PLOS Genetics | https://doi.org/10.1371/journal.pgen.1006812 June 14, 2017 13 / 15
S1 Table. Detailed results for known BMI, LDL-C, HDL-C, TG and TC loci.
(XLSX)
S2 Table. Study design, number of participants and sample quality control for genome-
wide association study cohorts.
(XLSX)
S3 Table. Information on genotyping methods, quality control of SNPs, imputation, and
statistical analysis.
(XLSX)
S1 Text. GIANT consortium contributors and their affiliations.
(PDF)
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